Results for tag: "Oncolytic Virus Drug"

The Oncolytic Virus Drug market is a subset of the Oncology Drugs market, which focuses on treatments for cancer. Oncolytic virus drugs are a type of biologic therapy that uses viruses to target and destroy cancer cells. These drugs are designed to selectively infect and kill cancer cells while leaving healthy cells unharmed. They can be used alone or in combination with other treatments such as chemotherapy or radiation therapy. Oncolytic virus drugs have the potential to improve the efficacy of existing treatments and reduce the side effects associated with them. Some companies in the Oncolytic Virus Drug market include Amgen, Merck, Pfizer, and Novartis. These companies are actively researching and developing new oncolytic virus drugs to treat a variety of cancers. Show Less Read more